Axsome Therapeutics (AXSM) Inventory (2022 - 2026)

Axsome Therapeutics' Inventory history runs 5 years deep, the most recent figure standing at $31.5 million for Q1 2026.

• In Q1 2026, Inventory rose 93.12% year-over-year to $31.5 million; the TTM figure through Mar 2026 stood at $31.5 million (up 93.12% YoY), while the FY2025 annual figure was $27.9 million, up 77.59% from the prior year.
• Inventory came in at $31.5 million for Q1 2026 at Axsome Therapeutics, up from $27.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $31.5 million in Q1 2026 to a low of $4.3 million in Q4 2022.
• A 5-year average of $15.6 million and a median of $15.2 million in 2023 frame the typical range for Inventory.
• On a YoY basis, Inventory climbed as much as 250.35% in 2023 and fell as far as 28.62% in 2023.
• Axsome Therapeutics' Inventory stood at $4.3 million in 2022, then surged by 250.35% to $15.1 million in 2023, then increased by 3.94% to $15.7 million in 2024, then jumped by 77.59% to $27.9 million in 2025, then climbed by 12.8% to $31.5 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $31.5 million, $27.9 million, and $23.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison